Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,089-2,100 of 4,306
Drug study icon
CompletedNCT00239356

Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Ottawa
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
France, Canada, United Kingdom, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT03287505

Aripiprazole IM Depot for Chinese people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Beijing
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 64 Years
Countries
China
Sponsor
Otsuka Beijing Research Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT00102063

Aripiprazole in Adolescents With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT01959035

Aripiprazole Once-monthly in people with Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
H. Lundbeck A/S
Condition
Schizophrenia
Drug study icon
CompletedNCT00102518

Aripiprazole Safety and Tolerability Study

This study is completed in the United States. It focuses on Schizophrenia.

Multiple locations, including Birmingham
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia, Bipolarity
Behavioral study icon
CompletedNCT02254733

Assertive Community Treatment With CBT and SST for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In San Diego
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
Veterans Medical Research Foundation
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02520024

Assessing the Impact of Self-directed Care, Within a Medicaid-funded Environment,on Participation and Community Living

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Bipolarity, ...BehavioralFrom 18 Years to 65 Years
Countries
Sponsor
Temple University Collaborative on Community Inclusion
Condition
Schizophrenia, Bipolarity, ...
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.